|
Oct 15
|
'Where we are today in biology AI is similar to GPT in 2020': An interview with the CEO of Africa's biggest AI startup
|
|
Oct 8
|
Pfizer, BioNTech win bid to invalidate CureVac's UK COVID vaccine patents
|
|
Jul 24
|
Triastek and BioNTech to develop 3D-printed RNA therapeutics
|
|
Jun 18
|
FDA puts partial clinical hold on BioNTech’s ADC trial after fatalities
|
|
Jun 18
|
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
|
|
Jun 17
|
Top Midday Stories: Nvidia Gets SCOTUS Review of Crypto Sales Lawsuit; Apple Supplier Develops Material for Solid-State Batteries; OpenAI Reportedly Launches Medical AI Tool; Walt Disney's 'Inside Out 2' Sets Biggest Opening of 2024; IQVentures to Acqu...
|
|
Jun 17
|
BioNTech Cancer Drug Licensed From MediLink Faces FDA Delay
|
|
May 11
|
We Discuss Why BioNTech SE's (NASDAQ:BNTX) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
|
|
May 8
|
BioNTech SE (NASDAQ:BNTX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
|
|
May 7
|
BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript
|
|
Feb 4
|
Five Upcoming Class Actions for Investors to Know About
|
|
Jan 9
|
UPDATE 2-BioNTech predicts return to revenue growth in 2025
|
|
Jan 9
|
Midday movers: Boeing, CrowdStrike and more
|
|
Jan 9
|
BioNTech predicts return to revenue growth in 2025
|
|
Jan 9
|
BioNTech expects 2024 revenues of about $3.3 bln
|
|
Jan 9
|
BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 24
|
15 Undervalued Defensive Stocks For 2024
|
|
Dec 21
|
BioNTech and DualityBio Receive FDA Breakthrough Therapy Designation for Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Endometrial Cancer
|
|
Dec 19
|
Why Is COVID-19 Vaccine Player CureVac Stock Plummeting Today?
|
|
Dec 19
|
UPDATE 2-German court quashes CureVac patent after challenge by BioNTech
|